How has been the historical performance of Mankind Pharma?
Mankind Pharma has shown significant growth over the past five years, with net sales increasing from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025, and profit after tax rising from INR 1,281.35 crore to INR 1,994.35 crore. The company's total assets also surged from INR 6,323.62 crore to INR 27,651.64 crore during this period.
Answer:The historical performance of Mankind Pharma shows significant growth in various financial metrics over the past five years.Breakdown:
Mankind Pharma's net sales have steadily increased from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025. Total operating income followed a similar trend, rising from INR 6,214.43 crore to INR 12,207.44 crore during the same period. The company's total expenditure, excluding depreciation, also grew, reaching INR 9,189.51 crore in March 2025, up from INR 4,566.33 crore in March 2021. Operating profit, excluding other income, increased from INR 1,648.10 crore in March 2021 to INR 3,017.93 crore in March 2025, while the operating profit margin slightly fluctuated, standing at 24.72% in March 2025. Profit before tax rose from INR 1,679.93 crore in March 2021 to INR 2,504.09 crore in March 2025, and profit after tax increased from INR 1,281.35 crore to INR 1,994.35 crore in the same timeframe. The consolidated net profit also showed growth, reaching INR 1,990.96 crore in March 2025 compared to INR 1,265.43 crore in March 2021. On the balance sheet, total assets surged from INR 6,323.62 crore in March 2021 to INR 27,651.64 crore in March 2025, while total liabilities increased from INR 6,323.62 crore to INR 27,651.64 crore. Cash flow from operating activities improved significantly, rising from INR 1,137 crore in March 2021 to INR 2,413 crore in March 2025, indicating a strong operational performance. Overall, Mankind Pharma has demonstrated robust growth in sales, profits, and asset base over the past five years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
